$BPTH small float.
Today's News, April 05, 2021
7:03 am ET
Bio-Path Holdings Completes Safety Cohort Of Triple Combination Of Prexigebersen, Decitabine And Venetoclax In Stage 2 Of Phase 2 Clinical Trial In Acute Myeloid Leukemia; Five Patients Responded To Treatment(Benzinga)